chloroquine has been researched along with alprostadil in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (18.18) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Merk, D; Willems, S | 1 |
Middleton, B | 1 |
Curtis, DH; Entwistle, A; Zalin, RJ | 1 |
Dada, OA; Nduka, EU | 1 |
Chandra, S; Dhawan, BN; Ohnishi, ST | 1 |
Alekhin, DI; Fokin, AA; Goloshchapova, ZhA; Mikhaĭlova, OA; Sumnaia, DB | 1 |
1 review(s) available for chloroquine and alprostadil
Article | Year |
---|---|
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
Topics: Chemistry, Pharmaceutical; Humans; Ligands; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2022 |
10 other study(ies) available for chloroquine and alprostadil
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Lysosome inhibitors enhance the ability of cyclic AMP-elevating agents to induce the LDL receptor in human vascular smooth muscle cells.
Topics: Alprostadil; Ammonium Chloride; Cells, Cultured; Chloroquine; Colforsin; Cyclic AMP; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipoproteins, LDL; Lysosomes; Muscle, Smooth, Vascular; Receptors, LDL | 1992 |
Myoblast fusion is regulated by a prostanoid of the one series independently of a rise in cyclic AMP.
Topics: Alprostadil; Animals; Arachidonic Acid; Arachidonic Acids; Cell Fusion; Cells, Cultured; Chick Embryo; Chloroquine; Cyclic AMP; Dinoprostone; Eicosanoic Acids; Indomethacin; Isoproterenol; Muscles; Propranolol; Prostaglandins E | 1986 |
Effect of acute chloroquine treatment on prostaglandin- and gonadotropin-stimulated testosterone secretion of rat testis.
Topics: Aging; Alprostadil; Animals; Chloroquine; Chorionic Gonadotropin; In Vitro Techniques; Male; Prostaglandins E; Rats; Rats, Inbred Strains; Testis; Testosterone | 1984 |
Reversal of chloroquine resistance in murine malaria parasites by prostaglandin derivatives.
Topics: Alprostadil; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Plasmodium berghei; Prostaglandins A; Prostaglandins B | 1993 |
[Administration of prostaglandins Ei and immunotherapy in management of various-genesis trophic ulcers].
Topics: Administration, Oral; Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunotherapy; Injections, Intravenous; Laser-Doppler Flowmetry; Leg Ulcer; Male; Prednisolone; Retrospective Studies; Time Factors; Treatment Outcome; Vasculitis; Vasodilator Agents; Venous Insufficiency | 2007 |